Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech SA
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
02-Jul-2024 / 11:25 CET/CEST
Dissemination of a French Regulatory News, transmitted by EQS Group.
The issuer is solely responsible for the content of this announcement.
Aubagne, July 2nd, 2024
Half-year liquidity contract statement for Sartorius Stedim Biotech
Under the liquidity contract entered into between Sartorius Stedim Biotech and Kepler Cheuvreux, the following resources appeared on the liquidity account on June 30th 2024:
As a reminder :
The following resources appeared on the last half year statement on 31 December 2023 on the liquidity account:
14,171 shares € 8,132,662.14 Number of executions on buy side on semester: 5,238 Number of executions on sell side on semester: 4,912 Traded volume on buy side on semester: 230,377 shares for € 50,832,014.40 Traded volume on sell side on semester: 239,123 shares for € 54,101,099.12
The following resources appeared on the liquidity account when the activity started:
0 shares € 10,000,000.00
The implementation of this report is carried out in accordance with AMF Decision N°2021-01 of June 22nd 2021 renewing the implementation of liquidity contracts for shares as an accepted market practice.
A profile of Sartorius Stedim Biotech
Sartorius Stedim Biotech is a leading international partner of the biopharmaceutical industry. As a provider of innovative solutions, the company based in Aubagne, France, helps its customers to manufacture biotech medications, such as cell and gene therapies, safely, rapidly, and economically. The shares of Sartorius Stedim Biotech S.A. are quoted on the Euronext Paris. The company has a strong global reach with manufacturing and R sites as well as sales entities in Europe, North America, and Asia. Sartorius Stedim Biotech regularly expands its portfolio through acquisitions of complementary technologies. In 2023, the company generated sales revenue of around 2.8 billion euros. Currently, more than 10,600 employees are working for customers around the globe.
Contact
Petra Müller
Head of Investor Relations
+49 (0)551.308.6035
Petra.mueller2@sartorius.com
Sartorius Stedim Biotech S.A.
Z.I. Les Paluds
Avenue de Jouques, CS 91051
13781 Aubagne Cedex, France
Phone: +33.(0)4.42.84.56.00
Fax: +33.(0)4.42.84.56.19
www.sartorius.com
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
Total
6,493
305,402
69,412,550.00
5,322
273,281
63,664,027.43
01/02/2024
16
1,000
244,350.00
107
4,495
1,109,725.60
01/03/2024
82
3,428
839,277.24
28
1,600
393,104.00
01/04/2024
91
3,592
864,342.96
41
1,662
404,397.84
01/05/2024
103
3,499
818,731.01
54
2,800
660,492.00
01/08/2024
92
3,350
786,881.50
47
2,500
590,150.00
01/09/2024
33
1,700
403,546.00
36
2,300
550,390.00
01/10/2024
85
3,800
912,152.00
44
1,901
460,346.16
01/11/2024
74
3,350
793,816.00
50
2,601
620,234.46
01/12/2024
65
3,500
821,065.00
59
2,600
616,070.00
01/15/2024
54
1,900
440,952.00
31
1,611
374,879.70
01/16/2024
165
4,500
1,004,760.00
32
1,900
427,994.00
01/17/2024
62
2,700
600,723.00
41
1,400
313,026.00
01/18/2024
54
2,400
533,784.00
37
1,800
403,704.00
01/19/2024
35
1,991
433,878.72
47
2,600
570,908.00
01/22/2024
41
1,700
378,658.00
63
2,500
559,900.00
01/23/2024
55
2,540
565,683.40
46
2,225
497,376.50
01/24/2024
71
3,300
740,487.00
72
3,176
716,473.84
01/25/2024
48
2,470
551,872.10
86
4,009
903,548.42
01/26/2024
54
2,605
614,884.20
125
6,725
1,618,976.50
01/29/2024
65
3,303
788,591.25
47
2,826
680,755.14
01/30/2024
108
5,073
1,186,879.08
83
4,604
1,103,716.92
01/31/2024
-
-
-
84
4,599
1,135,171.17
02/01/2024
58
2,675
663,186.00
29
1,423
354,711.21
02/02/2024
85
4,200
1,036,182.00
55
1,777
444,392.16
02/05/2024
43
1,700
411,400.00
55
3,002
732,217.82
02/06/2024
44
2,140
525,669.60
50
2,500
619,550.00
02/07/2024
91
4,300
1,051,436.00
56
3,500
880,390.00
02/08/2024
83
3,700
947,681.00
96
4,500
1,172,115.00
02/09/2024
67
3,700
930,624.00
71
3,700
936,729.00
02/12/2024
79
4,101
1,015,899.72
29
1,600
401,152.00
02/13/2024
77
3,821
921,816.25
29
1,600
388,464.00
02/14/2024
54
2,247
536,740.89
46
2,509
601,733.47
02/15/2024
40
1,860
449,692.20
68
2,891
702,137.17
02/16/2024
13
500
123,700.00
84
4,400
1,098,900.00
02/19/2024
41
2,313
579,221.46
60
3,000
757,890.00
02/20/2024
56
2,987
750,722.71
8
403
102,108.11
02/21/2024
82
4,100
1,010,937.00
35
1,700
426,955.00
02/22/2024
25
1,102
279,059.46
79
3,812
969,505.96
02/23/2024
55
2,448
612,979.20
21
900
225,846.00
02/26/2024
60
3,098
767,033.82
13
900
225,099.00
02/27/2024
34
2,200
543,840.00
45
2,700
670,707.00
02/28/2024
18
1,217
303,483.29
39
2,200
550,880.00
02/29/2024
21
1,024
259,307.52
85
3,585
912,633.45
03/01/2024
62
3,859
965,598.98
29
1,800
454,140.00
03/04/2024
41
2,200
551,694.00
29
1,500
377,325.00
03/05/2024
40
2,000
498,900.00
52
2,700
677,403.00
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
Total
6,493
305,402
69,412,550.00
5,322
273,281
63,664,027.43
03/06/2024
17
955
241,777.35
67
3,800
967,784.00
03/07/2024
7
512
132,469.76
88
4,400
1,152,800.00
03/08/2024
-
-
-
50
2,400
645,912.00
03/11/2024
70
3,152
847,856.48
59
2,700
730,269.00
03/12/2024
38
1,950
528,430.50
57
2,800
764,092.00
03/13/2024
66
3,400
922,794.00
36
2,159
590,054.70
03/14/2024
23
1,800
496,152.00
74
3,442
951,850.68
03/15/2024
80
4,440
1,217,670.00
32
1,904
524,456.80
03/18/2024
88
3,908
1,053,557.72
14
900
246,447.00
03/19/2024
55
2,351
617,983.86
45
2,300
607,016.00
03/20/2024
41
1,927
513,526.23
64
3,000
803,460.00
03/21/2024
49
2,400
659,112.00
100
3,750
1,034,362.50
03/22/2024
30
1,110
308,002.80
56
2,705
753,694.15
03/25/2024
90
3,300
904,497.00
1
100
27,850.00
03/26/2024
52
2,470
665,442.70
27
1,500
406,200.00
03/27/2024
118
5,190
1,360,506.60
55
3,000
793,440.00
03/28/2024
38
1,505
396,672.85
60
2,700
717,336.00
04/02/2024
73
2,900
750,752.00
31
1,500
389,790.00
04/03/2024
64
2,361
598,206.57
33
1,700
433,602.00
04/04/2024
34
1,600
409,648.00
34
2,000
514,700.00
04/05/2024
106
3,002
753,802.20
26
1,600
403,280.00
04/08/2024
36
1,697
430,410.11
45
2,720
693,083.20
04/09/2024
30
1,512
389,657.52
57
3,380
873,358.20
04/10/2024
80
3,888
993,461.76
32
958
249,108.74
04/11/2024
63
2,100
528,591.00
42
2,600
657,306.00
04/12/2024
48
2,900
735,962.00
30
1,000
257,900.00
04/15/2024
45
2,050
518,855.00
74
3,600
914,868.00
04/16/2024
83
2,900
725,696.00
42
2,300
577,852.00
04/17/2024
74
3,410
848,817.20
45
2,200
549,142.00
04/18/2024
101
7,230
1,519,746.00
21
1,200
259,296.00
04/19/2024
104
3,800
762,584.00
5
300
60,501.00
04/22/2024
58
2,800
548,716.00
30
1,700
336,974.00
04/23/2024
23
1,100
216,084.00
96
5,200
1,062,412.00
04/24/2024
36
2,000
419,000.00
44
2,600
547,846.00
04/25/2024
38
2,400
490,632.00
24
1,100
226,688.00
04/26/2024
16
800
164,824.00
61
2,400
498,672.00
04/29/2024
26
1,400
294,714.00
53
2,237
472,051.74
04/30/2024
55
3,000
618,330.00
6
300
62,499.00
05/02/2024
33
1,900
389,006.00
39
2,700
563,760.00
05/03/2024
17
1,000
208,960.00
55
2,913
611,205.66
05/06/2024
28
1,800
372,654.00
13
622
129,581.26
05/07/2024
40
1,615
333,077.60
39
1,800
372,870.00
05/08/2024
38
2,185
451,792.45
25
1,100
229,845.00
05/09/2024
23
1,000
204,240.00
34
1,800
371,358.00
05/10/2024
32
1,843
382,293.49
31
1,502
313,902.98
05/13/2024
36
2,164
441,694.04
21
1,200
247,476.00
Buy side
Sell side
Number of executions
Number of shares
Traded volume in EUR
Number of executions
Number of shares
Traded volume in EUR
Total
6,493
305,402
69,412,550.00
5,322
273,281
63,664,027.43
05/14/2024
17
1,200
248,148.00
92
3,998
833,343.12
05/15/2024
10
600
127,098.00
46
2,600
554,190.00
05/16/2024
129
6,093
1,239,864.57
12
800
167,264.00
05/17/2024
68
3,275
654,148.50
-
-
-
05/20/2024
51
2,805
552,837.45
40
2,300
454,963.00
05/21/2024
67
2,700
526,446.00
34
2,000
392,500.00
05/22/2024
47
2,055
395,608.05
44
2,500
484,075.00
05/23/2024
55
2,300
444,498.00
22
1,000
193,910.00
05/24/2024
54
2,604
493,353.84
38
2,600
494,260.00
05/27/2024
60
2,800
530,936.00
15
1,010
193,859.40
05/28/2024
49
1,900
355,851.00
14
1,000
188,050.00
05/29/2024
63
3,100
568,540.00
18
1,325
243,707.25
05/30/2024
31
1,032
187,854.96
17
800
146,624.00
05/31/2024
23
868
158,071.48
13
525
95,938.50
06/03/2024
28
1,700
306,816.00
24
1,575
287,626.50
06/04/2024
23
1,000
179,990.00
7
500
90,350.00
06/05/2024
4
300
54,441.00
34
1,800
328,482.00
06/06/2024
5
500
92,690.00
17
900
167,634.00
06/07/2024
19
1,400
259,616.00
24
1,000
186,660.00
06/10/2024
34
1,800
330,426.00
36
2,300
424,120.00
06/11/2024
16
700
132,153.00
53
2,800
530,376.00
06/12/2024
82
4,100
762,190.00
29
2,000
374,960.00
06/13/2024
57
2,100
380,268.00
25
1,500
272,625.00
06/14/2024
50
2,300
413,356.00
31
2,200
397,122.00
06/17/2024
58
3,200
560,736.00
7
600
106,308.00
06/18/2024
15
720
124,588.80
38
3,000
524,490.00
06/19/2024
111
5,380
884,741.00
-
-
-
06/20/2024
8
700
107,520.00
18
700
108,563.00
06/21/2024
20
1,200
185,316.00
16
900
140,787.00
06/24/2024
29
1,300
203,164.00
36
1,600
252,688.00
06/25/2024
42
2,500
393,375.00
33
1,700
268,583.00
06/26/2024
37
2,000
315,780.00
32
1,500
237,855.00
06/27/2024
49
2,450
380,093.00
19
1,019
158,688.87
06/28/2024
58
2,800
431,256.00
42
2,401
371,146.58
File: Sartorius Stedim Biotech_half-year report on liquidity contract_20240630
Language: English Company: Sartorius Stedim Biotech SA Avenue de Jouques 13781 Aubagne France Phone: +33 44 284 5600 E-mail: sartorius.presse@sartorius.com Internet: www.sartorius-stedim.com ISIN: FR0013154002 Euronext Ticker: DIM AMF Category: Share buyback / Disposal of own shares / Information relating to the liquidity contract EQS News ID: 1937983 End of Announcement EQS News Service
1937983 02-Jul-2024 CET/CEST